KYVERNA Trademark

Trademark Overview

On Wednesday, October 2, 2019, a trademark application was filed for KYVERNA with the United States Patent and Trademark Office. The USPTO has given the KYVERNA trademark a serial number of 88639742. The federal status of this trademark filing is REGISTERED as of Tuesday, November 14, 2023. This trademark is owned by Kyverna Therapeutics, Inc.. The KYVERNA trademark is filed in the Pharmaceutical Products category with the following description:

Therapeutic pharmaceutical for the treatment of autoimmune disease; therapeutic pharmaceuticals and cell therapy products in the nature of cells for medical or clinical use for the treatment of autoimmune disease; cell therapy products, namely, genetically engineered immune cells for medical or clinical use for the treatment of autoimmune disease
kyverna

General Information

Serial Number88639742
Word MarkKYVERNA
Filing DateWednesday, October 2, 2019
Status700 - REGISTERED
Status DateTuesday, November 14, 2023
Registration Number7219011
Registration DateTuesday, November 14, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 28, 2020

Trademark Statements

Goods and ServicesTherapeutic pharmaceutical for the treatment of autoimmune disease; therapeutic pharmaceuticals and cell therapy products in the nature of cells for medical or clinical use for the treatment of autoimmune disease; cell therapy products, namely, genetically engineered immune cells for medical or clinical use for the treatment of autoimmune disease
Translation of Words in MarkThe English translation of the word "KYVERNA" in the mark is "GOVERN" or "RULE".

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, October 6, 2019
Primary Code005
First Use Anywhere DateTuesday, September 19, 2023
First Use In Commerce DateTuesday, September 19, 2023

Trademark Owner History

Party NameKyverna Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressEmeryville, CA 94608
Party NameKyverna Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressEmeryville, CA 94608
Party NameKyverna Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBerkeley, CA 94710

Trademark Events

Event DateEvent Description
Tuesday, November 14, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 14, 2023REGISTERED-PRINCIPAL REGISTER
Saturday, October 7, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, October 6, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, September 26, 2023STATEMENT OF USE PROCESSING COMPLETE
Friday, September 22, 2023USE AMENDMENT FILED
Friday, September 22, 2023TEAS STATEMENT OF USE RECEIVED
Thursday, March 30, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 29, 2023SOU EXTENSION 5 GRANTED
Monday, March 20, 2023SOU EXTENSION 5 FILED
Wednesday, March 29, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, March 20, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, August 23, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 19, 2022SOU EXTENSION 4 GRANTED
Friday, August 19, 2022SOU EXTENSION 4 FILED
Friday, August 19, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, February 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 4, 2022SOU EXTENSION 3 GRANTED
Friday, February 4, 2022SOU EXTENSION 3 FILED
Friday, February 4, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, August 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 16, 2021SOU EXTENSION 2 GRANTED
Monday, August 16, 2021SOU EXTENSION 2 FILED
Monday, August 16, 2021SOU TEAS EXTENSION RECEIVED
Friday, March 26, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, March 26, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 26, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, March 13, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 11, 2021SOU EXTENSION 1 GRANTED
Thursday, March 11, 2021SOU EXTENSION 1 FILED
Thursday, March 11, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, September 22, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 28, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 28, 2020PUBLISHED FOR OPPOSITION
Wednesday, July 8, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 18, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 18, 2020EXAMINER'S AMENDMENT ENTERED
Thursday, June 18, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, June 18, 2020EXAMINERS AMENDMENT E-MAILED
Thursday, June 18, 2020EXAMINERS AMENDMENT -WRITTEN
Thursday, June 18, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 18, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 11, 2020ASSIGNED TO LIE
Wednesday, June 3, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, June 2, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, June 2, 2020FINAL REFUSAL E-MAILED
Tuesday, June 2, 2020FINAL REFUSAL WRITTEN
Thursday, May 14, 2020PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Thursday, May 14, 2020TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, January 7, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 7, 2020NON-FINAL ACTION E-MAILED
Tuesday, January 7, 2020NON-FINAL ACTION WRITTEN
Tuesday, January 7, 2020ASSIGNED TO EXAMINER
Sunday, October 6, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, October 5, 2019NEW APPLICATION ENTERED

Related Keywords

kyverna disease treatment autoimmune cells medical clinical therapeutic products therapy cell